Cargando…
“Is dopamine involved in Alzheimer's disease?”
Alzheimer's Disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline and dementia. Recent advances indicate that AD pathogenesis appears more complex than its mere neuropathology. Changes in synaptic plasticity, neuronal disarray and cell death are pathways co...
Autores principales: | Martorana, Alessandro, Koch, Giacomo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174765/ https://www.ncbi.nlm.nih.gov/pubmed/25309431 http://dx.doi.org/10.3389/fnagi.2014.00252 |
Ejemplares similares
-
Cerebellar theta burst stimulation modulates short latency afferent inhibition in Alzheimer's disease patients
por: Di Lorenzo, Francesco, et al.
Publicado: (2013) -
Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis
por: Pan, Xiongfeng, et al.
Publicado: (2019) -
Homotaurine Induces Measurable Changes of Short Latency Afferent Inhibition in a Group of Mild Cognitive Impairment Individuals
por: Martorana, Alessandro, et al.
Publicado: (2014) -
Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease
por: Krashia, Paraskevi, et al.
Publicado: (2019) -
Targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease
por: Shaikh, Ammara, et al.
Publicado: (2023)